Supply-side · Hospital & data groups

Hospital & data-org partnerships: clear control, reviewable, terminable

For hospital IT, medical affairs, ethics, legal, and data-group operations. The public page covers process and responsibility boundaries only; authorization packs, revenue share, and commercial terms exchange under NDA. Contracting entity: Beijing Langhui Technology Co., Ltd. (brand LumeSage).

Partnership flow (summary)

Initial org call: intended modality / disease / residency preference
Inventory: stock structure and eligible subset (summary-level)
Authorization / ethics / security path confirmation
On-prem or isolation plan (only when both sides confirm feasibility — never assumed)
Small-batch acceptance: format, de-ID checks, sampling rules
Use & access approval: who may view, train, or sublicense
Phased delivery or controlled use
Audit, incident notice, and termination

What hospitals care about most

Control: who approves access; who holds mapping keys
Residency: allowed or not; summary / features / de-ID objects
De-ID duty: on-site vs joint; how verification is recorded
Subcontracting: allowed or not; roster & confidentiality if yes
Audit & notice: hospital sampling; breach notice timelines

What data groups focus on

Authorization boundaries and downstream use limits
Multi-party revenue and metering (batch / license scope)
Audit pack list (summaries public; originals controlled)
No implication that “holding hospital data” equals full train/sublicense rights
No promised revenue or purchase volume

First call only needs this (no raw records)

Organization name and contact role
Data types that may be in scope (imaging / pathology / text — high level)
One usable contact channel
Preference for on-prem processing vs discussable off-site

Authorization status, ethics approvals, contracts, and identity proofs are follow-up materials — not first-submit requirements.

Compliance discipline

Not a medical-device promotion; no clinical efficacy claims. “Data stays on-prem” and isolation paths enter the contract only when both sides confirm feasibility. Cross-border transfer requires a separate written agreement.

Book a partnership call Get partnership checklist Compliance notes Data-card field sample

Operating & contracting entity: Beijing Langhui Technology Co., Ltd. (brand LumeSage). Business: date@lumesage.com · +86 15010400907

What makes a deliverable verifiable

Agree the content, access level and timing of these materials before delivery.

Task and counting: Define modality, inclusion rules, deduplication keys and units. Cases, studies, series, slices and annotations are distinct.
Source and permissions: Check provenance, lawful processing basis, training use, retention and redistribution. De-identification does not replace authorization.
Samples and distributions: Review samples, fields, strata and missingness. Sample approval is not batch acceptance.
Expertise and quality: Specify expert fit, review, sample denominators, disagreement resolution, rework and acceptance records.
Files and versions: Agree paths, checksums, versions, format checks and image–text pairing. Settle against accepted, deduplicated units.
Evaluation separation: Freeze tasks and rubrics; agree access, contamination checks, retest conditions and role disclosure.